During the past decade, National Center for Tumor Diseases, University Hospital Heidelberg conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Tumor Diseases, University Hospital Heidelberg" #1 collaborator was "Alcedis GmbH" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chair of Methods in Empirical Social Research, Institute of Sociology, Technische Universität Dresden" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "National Center for Tumor Diseases, University Hospital Heidelberg" are "Malignant Melanoma" (2 trials), "Cancer" (1 trials), "Cutaneous Malignant Melanoma" (1 trials), "Esophageal Adenocarcinoma" (1 trials) and "Esophageal Neoplasms" (1 trials). Many other conditions were trialed in "National Center for Tumor Diseases, University Hospital Heidelberg" in a lesser frequency.

Most popular intervention types in "National Center for Tumor Diseases, University Hospital Heidelberg" are "Drug" (5 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Biopsy" (1 trials), "Cobimetinib" (1 trials), "Dabrafenib" (1 trials) and "Maraviroc" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Center for Tumor Diseases, University Hospital Heidelberg" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National Center for Tumor Diseases, University Hospital Heidelberg". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Center for Tumor Diseases, University Hospital Heidelberg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Center for Tumor Diseases, University Hospital Heidelberg, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".